Performance of radiotherapy as a prognostic parameter for local control in rectal cancer patients:: Results of CAO/ARO/AIO-94

被引：0

作者：

Fietkau, R.

Roedel, C.

Hohenberger, W.

Raab, R.

Hess, C.

Hutter, M.

Hager, E.

Karstens, J.

Ewald, H.

Christen, N.

Martus, P.

Sauer, R.

机构：

[1] Univ Rostock, Rostock, Germany

[2] Univ Erlangen Nurnberg, Erlangen, Germany

[3] Univ Erlangen Nurnberg, Erlangen, Germany

[4] Klinikum Oldenberg, Oldenburg, Germany

[5] Univ Gottingen, D-3400 Gottingen, Germany

[6] KH Nordwest Frankfurt, Frankfurt, Germany

[7] Klinikum Klagenfurt, Klagenfurt, Austria

[8] Medizinische Hochshule, Hannover, Germany

[9] Univ Kiel, Kiel, Germany

[10] Klinikum Dresden Neustadt, Dresden, Germany

[11] Univ Berlin, Berlin, Germany

[12] Univ Rostock, Rostock, Germany

[13] Univ Erlangen Nurnberg, Erlangen, Germany

[14] Univ Erlangen Nurnberg, Erlangen, Germany

[15] Univ Gottingen, D-3400 Gottingen, Germany

[16] Univ Frankfurt, D-6000 Frankfurt, Germany

[17] KH N Frankfurt, Frankfurt, Germany

[18] Klinnukum Klagenfurt, Klagenfurt, Austria

[19] Univ Berlin, Berlin, Germany

来源：

RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

192

引用

页码：S76 / S76

页数：1

共 50 条

[31] Percutaneous radiotherapy combined with endorectal brachytherapy for organ preservation in elderly/frail patients with rectal cancer, the ACO/ARO/AIO-22 trial
Fleischmann, Maximilian
Dapper, Hendrik
Diefenhardt, Markus
Martin, Daniel
Tselis, Nikolaos
Roedel, Claus
Fokas, Emmanouil
ONKOLOGIE, 2024, 30 (02): : 129 - 132
[32] Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
Jochen Gaedcke
Malte Sahrhage
Marcel Ebeling
Azadeh Azizian
Felix Rühlmann
Markus Bernhardt
Marian Grade
Wolf Otto Bechstein
Christoph-Thomas Germer
Robert Grützmann
Pompiliu Piso
Ralf-Dieter Hofheinz
Ludger Staib
Tim Beißbarth
Rebekka Kosmala
Emmanouil Fokas
Claus Rödel
Michael Ghadimi
Scientific Reports, 15 (1)
[33] Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Diefenhardt, Markus
Ludmir, Ethan B.
Hofheinz, Ralf-Dieter
Ghadimi, Michael
Minsky, Bruce D.
Roedel, Claus
Fokas, Emmanouil
JAMA ONCOLOGY, 2020, 6 (09) : 1416 - 1421
[34] Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Fokas, Emmanouil
Schlenska-Lange, Anke
Polat, Buelent
Klautke, Gunther
Grabenbauer, Gerhard G.
Fietkau, Rainer
Kuhnt, Thomas
Staib, Ludger
Brunner, Thomas
Grosu, Anca-Ligia
Kirste, Simon
Jacobasch, Lutz
Allgaeuer, Michael
Flentje, Michael
Germer, Christoph-Thomas
Gruetzmann, Robert
Hildebrandt, Guido
Schwarzbach, Matthias
Bechstein, Wolf O.
Suelberg, Heiko
Friede, Tim
Gaedcke, Jochen
Ghadimi, Michael
Hofheinz, Ralf-Dieter
Roedel, Claus
JAMA ONCOLOGY, 2022, 8 (01)
[35] Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors
Skora, Tomasz
Nowak-Sadzikowska, Jadwiga
Martynow, Dariusz
Wszolek, Mariusz
Sas-Korczynska, Beata
JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (01) : 77 - 84
[36] Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial
Fokas, E.
Schlenska-Lange, A.
Polat, B.
Klautke, G.
Grabenbauer, G.
Fietkau, R.
Kuhnt, T.
Staib, L.
Brunner, T.
Grosu, A. -L.
Kirste, S.
Jacobasch, L.
Allgaeuer, M.
Flentje, M.
Germer, C.
Gruetzmann, R.
Hildebrandt, G.
Schwazbach, M.
Bechstein, W.
Suelberg, H.
Friede, T.
Gaedcke, J.
Ghadimi, M.
Hofheinz, R. -D.
Roedel, C.
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S7 - S8
[37] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: Initial results of the CAO/ARO/AIO-04 study [Präoperative Radiochemotherapie und postoperative Chemotherapie mit 5-FU und Oxaliplatin bei Rektumkarzinom: Erste Ergebnisse der CAO/ARO/AIO-04-Studie]
Reibetanz J.
Germer C.-T.
Der Chirurg, 2012, 83 (11): : 995 - 995
[38] Prognostic impact of local recurrence and timing of palliative radiotherapy in patients with unresectable recurrent rectal cancer.
Sakakida, Tomoki
Masuishi, Toshiki
Ishizuka, Yasunobu
Wakabayashi, Munehiro
Kodama, Hiroyuki
Narita, Yukiya
Honda, Kazunori
Taniguchi, Hiroya
Kadowaki, Shigenori
Ando, Masashi
Komori, Koji
Muro, Kei
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 132 - 132
[39] Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
Roedel, Claus
Liersch, Torsten
Becker, Heinz
Fietkau, Rainer
Hohenberger, Werner
Hothorn, Torsten
Graeven, Ullrich
Arnold, Dirk
Lang-Welzenbach, Marga
Raab, Hans-Rudolf
Suelberg, Heiko
Wittekind, Christian
Potapov, Sergej
Staib, Ludger
Hess, Clemens
Weigang-Koehler, Karin
Grabenbauer, Gerhard G.
Hoffmanns, Hans
Lindemann, Fritz
Schlenska-Lange, Anke
Folprecht, Gunnar
Sauer, Rolf
Lahmer, G.
Golcher, H.
Klautke, G.
Hartmann, A.
Rau, T.
Keilholz, L.
Henneking, K.
Muehldorfer, S.
Klein, S.
Stolte, M.
Staar, S.
Lehnert, T.
Hertenstein, B.
Freys, S. M.
Pflueger, K.-H.
Sendt, W.
Teyssen, S.
Latz, D.
Leibl, B. J.
Matek, W.
Grabenbauer, G. G.
Alfrink, M.
Kreczy, A.
Strobel, G. F.
Duewel, H.-J.
Bechstein, W. O.
Gog, C.
Boettcher, H.-D.
LANCET ONCOLOGY, 2012, 13 (07): : 679 - 687
[40] Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center
Marcus Zimmermann
Anne Richter
Stefan Weick
Florian Exner
Frederick Mantel
Markus Diefenhardt
Emmanouil Fokas
Rebekka Kosmala
Michael Flentje
Bülent Polat
Scientific Reports, 12

← 1 2 3 4 5 →